Destacado
Los sectores económicos en la era inteligente

Biotech under Stress

January 21, 2025
16:15–17:00 (Europe/Amsterdam zona horaria)

Acerca de esta sesión

Despite the 10% success rate for commercial biotech, bio-innovation remains uniquely positioned to address society’s biggest challenges in healthcare, manufacturing and energy. What is the benefit of applying bio-innovation to commercial applications and how can industry better respond to the demands of these challenges?

This is a livestreamed session.

Ponentes

JB
Jelena Begovic
Minister of Science, Technological Development and Innovation
Ministry of Science, Technological Development and Innovation of Serbia
EH
Edith Heard
General Director
European Molecular Biology Laboratory (EMBL)
SR
Sarah Reisinger
Chief Science and Research Officer
dsm-firmenich
GY
George Yancopoulos
Founding Scientist, President and Chief Scientific Officer
Regeneron Pharmaceuticals